This page is part of the FHIR Specification (v3.0.2: STU 3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4 R3
V2-0292.cs.xml

Vocabulary Work Group
Maturity Level: N/A
Ballot Status: Informative
Raw XML (canonical form)
FHIR Value set/code system definition for HL7 v2 table 0292 ( Vaccines Administered (code = CVX) (parenteral, un)
<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="v2-0292"/> 
  <meta> 
    <profile value="http://hl7.org/fhir/StructureDefinition/shareablecodesystem"/> 
  </meta> 
  <text> 
    <status value="additional"/> 
    <div xmlns="http://www.w3.org/1999/xhtml">
      <p> Vaccines Administered (code = CVX) (parenteral, un</p> 

      <table class="grid">
        <tr> 
          <td> 
            <b> Code</b> 
          </td> 
          <td> 
            <b> Description</b> 
          </td> 
          <td> 
            <b> Nederlands (Dutch)</b> 
          </td> 
          <td> 
            <b> Comment</b> 
          </td> 
          <td> 
            <b> Version</b> 
          </td> 
        </tr> 
        <tr> 
          <td> 01
            <a name="01"> </a> 
          </td> 
          <td> DTP</td> 
          <td> DKT - difterie-kinkhoest-tetanus</td> 
          <td> diphtheria, tetanus toxoids and pertussis vaccine</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 02
            <a name="02"> </a> 
          </td> 
          <td> OPV</td> 
          <td> OPV</td> 
          <td> poliovirus vaccine, live, oral</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 03
            <a name="03"> </a> 
          </td> 
          <td> MMR</td> 
          <td> BMR - bof, mazelen, rodehond</td> 
          <td> measles, mumps and rubella virus vaccine</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 04
            <a name="04"> </a> 
          </td> 
          <td> M/R</td> 
          <td> M/R</td> 
          <td> measles and rubella virus vaccine</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 05
            <a name="05"> </a> 
          </td> 
          <td> measles</td> 
          <td> mazelen</td> 
          <td> measles virus vaccine</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 06
            <a name="06"> </a> 
          </td> 
          <td> rubella</td> 
          <td> rodehond</td> 
          <td> rubella virus vaccine</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 07
            <a name="07"> </a> 
          </td> 
          <td> mumps</td> 
          <td> bof</td> 
          <td> mumps virus vaccine</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 08
            <a name="08"> </a> 
          </td> 
          <td> Hep B, adolescent or pediatric</td> 
          <td> Hep B, adolescent of pediatrie</td> 
          <td> hepatitis B vaccine, pediatric or pediatric/adolescent dosage</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 09
            <a name="09"> </a> 
          </td> 
          <td> Td (adult)</td> 
          <td> DT - difterie en tetanus (volwassene)</td> 
          <td> tetanus and diphtheria toxoids, adsorbed for adult use</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 10
            <a name="10"> </a> 
          </td> 
          <td> IPV</td> 
          <td> IPV</td> 
          <td> poliovirus vaccine, inactivated</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 100
            <a name="100"> </a> 
          </td> 
          <td> pneumococcal conjugate</td> 
          <td> pneumokokken conjugaat</td> 
          <td> pneumococcal conjugate vaccine, polyvalent</td> 
          <td> added v2.4</td> 
        </tr> 
        <tr> 
          <td> 101
            <a name="101"> </a> 
          </td> 
          <td> typhoid, ViCPs</td> 
          <td> tyfus, ViCPs</td> 
          <td> typhoid Vi capsular polysaccharide vaccine</td> 
          <td> added v2.4</td> 
        </tr> 
        <tr> 
          <td> 102
            <a name="102"> </a> 
          </td> 
          <td> DTP-Hib-Hep B</td> 
          <td> DKT-Hib-Hep B</td> 
          <td> DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine</td> 
          <td> added v2.5</td> 
        </tr> 
        <tr> 
          <td> 103
            <a name="103"> </a> 
          </td> 
          <td> meningococcal C conjugate</td> 
          <td> meningokokken C conjugaat</td> 
          <td> meningococcal C conjugate vaccine</td> 
          <td> added v2.5</td> 
        </tr> 
        <tr> 
          <td> 104
            <a name="104"> </a> 
          </td> 
          <td> Hep A-Hep B</td> 
          <td> Hep A-Hep B</td> 
          <td> hepatitis A and hepatitis B vaccine</td> 
          <td> added v2.5</td> 
        </tr> 
        <tr> 
          <td> 105
            <a name="105"> </a> 
          </td> 
          <td> vaccinia (smallpox) diluted</td> 
          <td> vaccinia (pokken) verzwakt</td> 
          <td> vaccinia (smallpox) vaccine, diluted</td> 
          <td> added v2.5</td> 
        </tr> 
        <tr> 
          <td> 106
            <a name="106"> </a> 
          </td> 
          <td> DTaP, 5 pertussis antigens6</td> 
          <td> DaKT, 5 kinkhoest antigenen6</td> 
          <td> diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens</td> 
          <td> added v2.5</td> 
        </tr> 
        <tr> 
          <td> 107
            <a name="107"> </a> 
          </td> 
          <td> DTaP, NOS</td> 
          <td> DaKT, niet anders gespecificeerd</td> 
          <td> diphtheria, tetanus toxoids and acellular pertussis vaccine, NOS</td> 
          <td> added v2.5</td> 
        </tr> 
        <tr> 
          <td> 108
            <a name="108"> </a> 
          </td> 
          <td> meningococcal, NOS</td> 
          <td> meningokokken, niet anders gespecificeerd</td> 
          <td> meningococcal vaccine, NOS</td> 
          <td> added v2.5</td> 
        </tr> 
        <tr> 
          <td> 109
            <a name="109"> </a> 
          </td> 
          <td> pneumococcal, NOS</td> 
          <td> pneumokokken, niet anders gespecificeerd</td> 
          <td> pneumococcal vaccine, NOS</td> 
          <td> added v2.5</td> 
        </tr> 
        <tr> 
          <td> 11
            <a name="11"> </a> 
          </td> 
          <td> pertussis</td> 
          <td> kinkhoest</td> 
          <td> pertussis vaccine</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 110
            <a name="110"> </a> 
          </td> 
          <td> DTaP-Hep B-IPV</td> 
          <td> DaKT-Hep B-IPV</td> 
          <td> DTaP-hepatitis B and poliovirus vaccine</td> 
          <td> added v2.6</td> 
        </tr> 
        <tr> 
          <td> 111
            <a name="111"> </a> 
          </td> 
          <td> influenza, live, intranasal</td> 
          <td> influenza, levend, intranasaal</td> 
          <td> influenza virus vaccine, live, attenuated, for intranasal use</td> 
          <td> added v2.6</td> 
        </tr> 
        <tr> 
          <td> 112
            <a name="112"> </a> 
          </td> 
          <td> tetanus toxoid, NOS</td> 
          <td> tetanus toxoïde, niet anders gespecificeerd</td> 
          <td> tetanus toxoid, NOS</td> 
          <td> added v2.6</td> 
        </tr> 
        <tr> 
          <td> 113
            <a name="113"> </a> 
          </td> 
          <td> Td (adult)</td> 
          <td> DT - difterie en tetanus (volwassene)</td> 
          <td> tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use</td> 
          <td> added v2.6</td> 
        </tr> 
        <tr> 
          <td> 114
            <a name="114"> </a> 
          </td> 
          <td> meningococcal A,C,Y,W-135 diphtheria conjugate</td> 
          <td> meningokokken A,C,Y,W-135 difterie conjugaat</td> 
          <td> meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine
               (MCV4)</td> 
          <td> added v2.6</td> 
        </tr> 
        <tr> 
          <td> 115
            <a name="115"> </a> 
          </td> 
          <td> Tdap</td> 
          <td> tetanus toxoïde, verminderde difterie toxoïde, en acellulaire kinkhoest</td> 
          <td> tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed</td> 
          <td> added v2.6</td> 
        </tr> 
        <tr> 
          <td> 116
            <a name="116"> </a> 
          </td> 
          <td> rotavirus, pentavalent</td> 
          <td> rotavirus, pentavalent</td> 
          <td> rotavirus, live, pentavalent vaccine</td> 
          <td> added v2.6</td> 
        </tr> 
        <tr> 
          <td> 117
            <a name="117"> </a> 
          </td> 
          <td> VZIG (IND)</td> 
          <td> VZIG (IND)</td> 
          <td> varicella zoster immune globulin (Investigational New Drug)</td> 
          <td> added v2.6</td> 
        </tr> 
        <tr> 
          <td> 118
            <a name="118"> </a> 
          </td> 
          <td> HPV, bivalent</td> 
          <td> HPV, bivalent</td> 
          <td> human papilloma virus vaccine, bivalent</td> 
          <td> added v2.6</td> 
        </tr> 
        <tr> 
          <td> 119
            <a name="119"> </a> 
          </td> 
          <td> rotavirus, monovalent</td> 
          <td> rotavirus, monovalent</td> 
          <td> rotavirus, live, monovalent vaccine</td> 
          <td> added v2.6</td> 
        </tr> 
        <tr> 
          <td> 12
            <a name="12"> </a> 
          </td> 
          <td> diphtheria antitoxin</td> 
          <td> difterie antitoxine</td> 
          <td> diphtheria antitoxin</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 120
            <a name="120"> </a> 
          </td> 
          <td> DTaP-Hib-IPV</td> 
          <td> DaKT-Hib-IPV</td> 
          <td> diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type
               b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)</td> 
          <td> added v2.6</td> 
        </tr> 
        <tr> 
          <td> 121
            <a name="121"> </a> 
          </td> 
          <td> zoster</td> 
          <td> gordelroos</td> 
          <td> zoster vaccine, live</td> 
          <td> added v2.6</td> 
        </tr> 
        <tr> 
          <td> 122
            <a name="122"> </a> 
          </td> 
          <td> rotavirus, NOS1</td> 
          <td> rotavirus, niet anders gespecificeerd1</td> 
          <td> rotavirus vaccine, NOS</td> 
          <td> added v2.6</td> 
        </tr> 
        <tr> 
          <td> 13
            <a name="13"> </a> 
          </td> 
          <td> TIG</td> 
          <td> TIG</td> 
          <td> tetanus immune globulin</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 14
            <a name="14"> </a> 
          </td> 
          <td> IG, NOS</td> 
          <td> IG, niet anders gespecificeerd</td> 
          <td> immune globulin, NOS</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 15
            <a name="15"> </a> 
          </td> 
          <td> influenza, split (incl. purified surface antigen)</td> 
          <td> influenza, gesplitst (incl. gezuiverd oppervlakte antigen)</td> 
          <td> influenza virus vaccine, split virus (incl. purified surface antigen)</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 16
            <a name="16"> </a> 
          </td> 
          <td> influenza, whole</td> 
          <td> influenza, geheel</td> 
          <td> influenza virus vaccine, whole virus</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 17
            <a name="17"> </a> 
          </td> 
          <td> Hib, NOS</td> 
          <td> Hib, niet anders gespecificeerd</td> 
          <td> Haemophilus influenzae type b vaccine, conjugate NOS</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 18
            <a name="18"> </a> 
          </td> 
          <td> rabies, intramuscular injection</td> 
          <td> hondsdolheid, intramusculaire injectie</td> 
          <td> rabies vaccine, for intramuscular injection</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 19
            <a name="19"> </a> 
          </td> 
          <td> BCG</td> 
          <td> BCG</td> 
          <td> Bacillus Calmette-Guerin vaccine</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 20
            <a name="20"> </a> 
          </td> 
          <td> DTaP</td> 
          <td> DaKT -difterie-acellulaire kinkhoest-tetanus</td> 
          <td> diphtheria, tetanus toxoids and acellular pertussis vaccine</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 21
            <a name="21"> </a> 
          </td> 
          <td> varicella</td> 
          <td> varicella</td> 
          <td> varicella virus vaccine</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 22
            <a name="22"> </a> 
          </td> 
          <td> DTP-Hib</td> 
          <td> DKT-Hib</td> 
          <td> DTP-Haemophilus influenzae type b conjugate vaccine</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 23
            <a name="23"> </a> 
          </td> 
          <td> plague</td> 
          <td> pest</td> 
          <td> plague vaccine</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 24
            <a name="24"> </a> 
          </td> 
          <td> anthrax</td> 
          <td> miltvuur</td> 
          <td> anthrax vaccine</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 25
            <a name="25"> </a> 
          </td> 
          <td> typhoid, oral</td> 
          <td> tyfus, oral</td> 
          <td> typhoid vaccine, live, oral</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 26
            <a name="26"> </a> 
          </td> 
          <td> cholera</td> 
          <td> cholera</td> 
          <td> cholera vaccine</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 27
            <a name="27"> </a> 
          </td> 
          <td> botulinum antitoxin</td> 
          <td> botulisme antitoxine</td> 
          <td> botulinum antitoxin</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 28
            <a name="28"> </a> 
          </td> 
          <td> DT (pediatric)</td> 
          <td> DT - difterie-tetanus (pediatrie)</td> 
          <td> diphtheria and tetanus toxoids, adsorbed for pediatric use</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 29
            <a name="29"> </a> 
          </td> 
          <td> CMVIG</td> 
          <td> CMVIG</td> 
          <td> cytomegalovirus immune globulin, intravenous</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 30
            <a name="30"> </a> 
          </td> 
          <td> HBIG</td> 
          <td> HBIG</td> 
          <td> hepatitis B immune globulin</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 31
            <a name="31"> </a> 
          </td> 
          <td> Hep A, pediatric, NOS</td> 
          <td> Hep A, pediatrie, niet anders gespecificeerd</td> 
          <td> hepatitis A vaccine, pediatric dosage, NOS</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 32
            <a name="32"> </a> 
          </td> 
          <td> meningococcal</td> 
          <td> meningokokken</td> 
          <td> meningococcal polysaccharide vaccine (MPSV4)</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 33
            <a name="33"> </a> 
          </td> 
          <td> pneumococcal</td> 
          <td> pneumokokken</td> 
          <td> pneumococcal polysaccharide vaccine</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 34
            <a name="34"> </a> 
          </td> 
          <td> RIG</td> 
          <td> hondsdolheid immunoglobuline</td> 
          <td> rabies immune globulin</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 35
            <a name="35"> </a> 
          </td> 
          <td> tetanus toxoid</td> 
          <td> tetanus toxoïde</td> 
          <td> tetanus toxoid, adsorbed</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 36
            <a name="36"> </a> 
          </td> 
          <td> VZIG</td> 
          <td> VZIG</td> 
          <td> varicella zoster immune globulin</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 37
            <a name="37"> </a> 
          </td> 
          <td> yellow fever</td> 
          <td> gele koorts</td> 
          <td> yellow fever vaccine</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 38
            <a name="38"> </a> 
          </td> 
          <td> rubella/mumps</td> 
          <td> rodehond/bof</td> 
          <td> rubella and mumps virus vaccine</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 39
            <a name="39"> </a> 
          </td> 
          <td> Japanese encephalitis</td> 
          <td> Japanse encefalitis</td> 
          <td> Japanese encephalitis vaccine</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 40
            <a name="40"> </a> 
          </td> 
          <td> rabies, intradermal injection</td> 
          <td> hondsdolheid, intradermale injectie</td> 
          <td> rabies vaccine, for intradermal injection</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 41
            <a name="41"> </a> 
          </td> 
          <td> typhoid, parenteral</td> 
          <td> tyfus, parenteraal</td> 
          <td> typhoid vaccine, parenteral, other than acetone-killed, dried</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 42
            <a name="42"> </a> 
          </td> 
          <td> Hep B, adolescent/high risk infant2</td> 
          <td> Hep B, adolescent/hoogrisico zuigeling2</td> 
          <td> hepatitis B vaccine, adolescent/high risk infant dosage</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 43
            <a name="43"> </a> 
          </td> 
          <td> Hep B, adult4</td> 
          <td> Hep B, volwassen4</td> 
          <td> hepatitis B vaccine, adult dosage</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 44
            <a name="44"> </a> 
          </td> 
          <td> Hep B, dialysis</td> 
          <td> Hep B, dialyse</td> 
          <td> hepatitis B vaccine, dialysis patient dosage</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 45
            <a name="45"> </a> 
          </td> 
          <td> Hep B, NOS</td> 
          <td> Hep B, niet anders gespecificeerd</td> 
          <td> hepatitis B vaccine, NOS</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 46
            <a name="46"> </a> 
          </td> 
          <td> Hib (PRP-D)</td> 
          <td> Hib (PRP-D)</td> 
          <td> Haemophilus influenzae type b vaccine, PRP-D conjugate</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 47
            <a name="47"> </a> 
          </td> 
          <td> Hib (HbOC)</td> 
          <td> Hib (HbOC)</td> 
          <td> Haemophilus influenzae type b vaccine, HbOC conjugate</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 48
            <a name="48"> </a> 
          </td> 
          <td> Hib (PRP-T)</td> 
          <td> Hib (PRP-T)</td> 
          <td> Haemophilus influenzae type b vaccine, PRP-T conjugate</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 49
            <a name="49"> </a> 
          </td> 
          <td> Hib (PRP-OMP)</td> 
          <td> Hib (PRP-OMP)</td> 
          <td> Haemophilus influenzae type b vaccine, PRP-OMP conjugate</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 50
            <a name="50"> </a> 
          </td> 
          <td> DTaP-Hib</td> 
          <td> DaKT-Hib</td> 
          <td> DTaP-Haemophilus influenzae type b conjugate vaccine</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 51
            <a name="51"> </a> 
          </td> 
          <td> Hib-Hep B</td> 
          <td> Hib-Hep B</td> 
          <td> Haemophilus influenzae type b conjugate and Hepatitis B vaccine</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 52
            <a name="52"> </a> 
          </td> 
          <td> Hep A, adult</td> 
          <td> Hep A, volwassene</td> 
          <td> hepatitis A vaccine, adult dosage</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> 53
            <a name="53"> </a> 
          </td> 
          <td> typhoid, parenteral, AKD (U.S. military)</td> 
          <td> tyfus, parenteraal, AKD (Amerikaanse leger)</td> 
          <td> typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 54
            <a name="54"> </a> 
          </td> 
          <td> adenovirus, type 4</td> 
          <td> adenovirus, type 4</td> 
          <td> adenovirus vaccine, type 4, live, oral</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 55
            <a name="55"> </a> 
          </td> 
          <td> adenovirus, type 7</td> 
          <td> adenovirus, type 7</td> 
          <td> adenovirus vaccine, type 7, live, oral</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 56
            <a name="56"> </a> 
          </td> 
          <td> dengue fever</td> 
          <td> knokkelkoorts</td> 
          <td> dengue fever vaccine</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 57
            <a name="57"> </a> 
          </td> 
          <td> hantavirus</td> 
          <td> hantavirus</td> 
          <td> hantavirus vaccine</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 58
            <a name="58"> </a> 
          </td> 
          <td> Hep C</td> 
          <td> Hep C</td> 
          <td> hepatitis C vaccine</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 59
            <a name="59"> </a> 
          </td> 
          <td> Hep E</td> 
          <td> Hep E</td> 
          <td> hepatitis E vaccine</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 60
            <a name="60"> </a> 
          </td> 
          <td> herpes simplex 2</td> 
          <td> herpes simplex 2</td> 
          <td> herpes simplex virus, type 2 vaccine</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 61
            <a name="61"> </a> 
          </td> 
          <td> HIV</td> 
          <td> HIV</td> 
          <td> human immunodeficiency virus vaccine</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 62
            <a name="62"> </a> 
          </td> 
          <td> HPV, quadrivalent</td> 
          <td> HPV, quadrivalent</td> 
          <td> human papilloma virus vaccine, quadrivalent</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 63
            <a name="63"> </a> 
          </td> 
          <td> Junin virus</td> 
          <td> Junín virus</td> 
          <td> Junin virus vaccine</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 64
            <a name="64"> </a> 
          </td> 
          <td> leishmaniasis</td> 
          <td> leishmaniase</td> 
          <td> leishmaniasis vaccine</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 65
            <a name="65"> </a> 
          </td> 
          <td> leprosy</td> 
          <td> lepra</td> 
          <td> leprosy vaccine</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 66
            <a name="66"> </a> 
          </td> 
          <td> Lyme disease</td> 
          <td> ziekte van Lyme</td> 
          <td> Lyme disease vaccine</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 67
            <a name="67"> </a> 
          </td> 
          <td> malaria</td> 
          <td> malaria</td> 
          <td> malaria vaccine</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 68
            <a name="68"> </a> 
          </td> 
          <td> melanoma</td> 
          <td> melanoom</td> 
          <td> melanoma vaccine</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 69
            <a name="69"> </a> 
          </td> 
          <td> parainfluenza-3</td> 
          <td> parainfluenza-3</td> 
          <td> parainfluenza-3 virus vaccine</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 70
            <a name="70"> </a> 
          </td> 
          <td> Q fever</td> 
          <td> Q-koorts</td> 
          <td> Q fever vaccine</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 71
            <a name="71"> </a> 
          </td> 
          <td> RSV-IGIV</td> 
          <td> RSV-IGIV</td> 
          <td> respiratory syncytial virus immune globulin, intravenous</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 72
            <a name="72"> </a> 
          </td> 
          <td> rheumatic fever</td> 
          <td> reumatische koorts</td> 
          <td> rheumatic fever vaccine</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 73
            <a name="73"> </a> 
          </td> 
          <td> Rift Valley fever</td> 
          <td> Riftdalkoorts</td> 
          <td> Rift Valley fever vaccine</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 74
            <a name="74"> </a> 
          </td> 
          <td> rotavirus, tetravalent</td> 
          <td> rotavirus, tetravalent</td> 
          <td> rotavirus, live, tetravalent vaccine</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 75
            <a name="75"> </a> 
          </td> 
          <td> vaccinia (smallpox)</td> 
          <td> vaccinia (pokken)</td> 
          <td> vaccinia (smallpox) vaccine</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 76
            <a name="76"> </a> 
          </td> 
          <td> Staphylococcus bacterio lysate</td> 
          <td> Staphylococcus bacterio lysate</td> 
          <td> Staphylococcus bacteriophage lysate</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 77
            <a name="77"> </a> 
          </td> 
          <td> tick-borne encephalitis</td> 
          <td> frühsommer-meningoenzephalitis vaccin</td> 
          <td> tick-borne encephalitis vaccine</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 78
            <a name="78"> </a> 
          </td> 
          <td> tularemia vaccine</td> 
          <td> tularemia vaccin</td> 
          <td> tularemia vaccine</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 79
            <a name="79"> </a> 
          </td> 
          <td> vaccinia immune globulin</td> 
          <td> vaccinia immunoglobuline</td> 
          <td> vaccinia immune globulin</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 80
            <a name="80"> </a> 
          </td> 
          <td> VEE, live</td> 
          <td> VEE, levend</td> 
          <td> Venezuelan equine encephalitis, live, attenuated</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 81
            <a name="81"> </a> 
          </td> 
          <td> VEE, inactivated</td> 
          <td> VEE, inactief</td> 
          <td> Venezuelan equine encephalitis, inactivated</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 82
            <a name="82"> </a> 
          </td> 
          <td> adenovirus, NOS1</td> 
          <td> adenovirus, niet anders gespecificeerd1</td> 
          <td> adenovirus vaccine, NOS</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 83
            <a name="83"> </a> 
          </td> 
          <td> Hep A, ped/adol, 2 dose</td> 
          <td> Hep A, ped/adol, 2 dosis</td> 
          <td> hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 84
            <a name="84"> </a> 
          </td> 
          <td> Hep A, ped/adol, 3 dose</td> 
          <td> Hep A, ped/adol, 3 dosis</td> 
          <td> hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 85
            <a name="85"> </a> 
          </td> 
          <td> Hep A, NOS</td> 
          <td> Hep A, niet anders gespecificeerd</td> 
          <td> hepatitis A vaccine, NOS</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 86
            <a name="86"> </a> 
          </td> 
          <td> IG</td> 
          <td> IG</td> 
          <td> immune globulin, intramuscular</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 87
            <a name="87"> </a> 
          </td> 
          <td> IGIV</td> 
          <td> IGIV</td> 
          <td> immune globulin, intravenous</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 88
            <a name="88"> </a> 
          </td> 
          <td> influenza, NOS</td> 
          <td> influenza, niet anders gespecificeerd</td> 
          <td> influenza virus vaccine, NOS</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 89
            <a name="89"> </a> 
          </td> 
          <td> polio, NOS</td> 
          <td> polio, niet anders gespecificeerd</td> 
          <td> poliovirus vaccine, NOS</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 90
            <a name="90"> </a> 
          </td> 
          <td> rabies, NOS</td> 
          <td> hondsdolheid, niet anders gespecificeerd</td> 
          <td> rabies vaccine, NOS</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 91
            <a name="91"> </a> 
          </td> 
          <td> typhoid, NOS</td> 
          <td> tyfus, niet anders gespecificeerd</td> 
          <td> typhoid vaccine, NOS</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 92
            <a name="92"> </a> 
          </td> 
          <td> VEE, NOS</td> 
          <td> VEE, niet anders gespecificeerd</td> 
          <td> Venezuelan equine encephalitis vaccine, NOS</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> 93
            <a name="93"> </a> 
          </td> 
          <td> RSV-MAb</td> 
          <td> RSV-MAb</td> 
          <td> respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular</td> 
          <td> added v2.4</td> 
        </tr> 
        <tr> 
          <td> 94
            <a name="94"> </a> 
          </td> 
          <td> MMRV</td> 
          <td> BMRV - bof, mazelen, rodehond en varicella</td> 
          <td> measles, mumps, rubella, and varicella virus vaccine</td> 
          <td> added v2.4</td> 
        </tr> 
        <tr> 
          <td> 95
            <a name="95"> </a> 
          </td> 
          <td> TST-OT tine test</td> 
          <td> TST-OT tine test</td> 
          <td> tuberculin skin test; old tuberculin, multipuncture device</td> 
          <td> added v2.4</td> 
        </tr> 
        <tr> 
          <td> 96
            <a name="96"> </a> 
          </td> 
          <td> TST-PPD intradermal</td> 
          <td> TST-PPD intradermal</td> 
          <td> tuberculin skin test; purified protein derivative solution, intradermal</td> 
          <td> added v2.4</td> 
        </tr> 
        <tr> 
          <td> 97
            <a name="97"> </a> 
          </td> 
          <td> TST-PPD tine test</td> 
          <td> TST-PPD tine test</td> 
          <td> tuberculin skin test; purified protein derivative, multipuncture device</td> 
          <td> added v2.4</td> 
        </tr> 
        <tr> 
          <td> 98
            <a name="98"> </a> 
          </td> 
          <td> TST, NOS</td> 
          <td> TST, niet anders gespecificeerd</td> 
          <td> tuberculin skin test; NOS</td> 
          <td> added v2.4</td> 
        </tr> 
        <tr> 
          <td> 99
            <a name="99"> </a> 
          </td> 
          <td> RESERVED - do not use3</td> 
          <td> GERESERVEERD - niet gebruiken3</td> 
          <td> RESERVED - do not use</td> 
          <td> added v2.4</td> 
        </tr> 
        <tr> 
          <td> 998
            <a name="998"> </a> 
          </td> 
          <td> no vaccine administered5</td> 
          <td> geen vaccin toegediend5</td> 
          <td> no vaccine administered</td> 
          <td> added v2.5</td> 
        </tr> 
        <tr> 
          <td> 999
            <a name="999"> </a> 
          </td> 
          <td> unknown</td> 
          <td> onbekend</td> 
          <td> unknown vaccine or immune globulin</td> 
          <td> added v2.4</td> 
        </tr> 
      </table> 

    </div> 
  </text> 
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-ballot-status">
    <valueString value="External"/> 
  </extension> 
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm">
    <valueInteger value="0"/> 
  </extension> 
  <url value="http://hl7.org/fhir/v2/0292"/> 
  <identifier> 
    <system value="urn:ietf:rfc:3986"/> 
    <value value="urn:oid:2.16.840.1.113883.18.182"/> 
  </identifier> 
  <version value="2.8.2"/> 
  <name value="v2 Vaccines Administered (code = CVX) (parenteral, un"/> 
  <status value="active"/> 
  <experimental value="false"/> 
  <publisher value="HL7, Inc"/> 
  <contact> 
    <telecom> 
      <system value="url"/> 
      <value value="http://hl7.org"/> 
    </telecom> 
  </contact> 
  <description value="FHIR Value set/code system definition for HL7 v2 table 0292 ( Vaccines Administered (code
     = CVX) (parenteral, un)"/> 
  <caseSensitive value="false"/> 
  <valueSet value="http://hl7.org/fhir/ValueSet/v2-0292"/> 
  <content value="complete"/> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="diphtheria, tetanus toxoids and pertussis vaccine"/> 
    </extension> 
    <code value="01"/> 
    <display value="DTP"/> 
    <designation> 
      <language value="nl"/> 
      <value value="DKT - difterie-kinkhoest-tetanus"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="poliovirus vaccine, live, oral"/> 
    </extension> 
    <code value="02"/> 
    <display value="OPV"/> 
    <designation> 
      <language value="nl"/> 
      <value value="OPV"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="measles, mumps and rubella virus vaccine"/> 
    </extension> 
    <code value="03"/> 
    <display value="MMR"/> 
    <designation> 
      <language value="nl"/> 
      <value value="BMR - bof, mazelen, rodehond"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="measles and rubella virus vaccine"/> 
    </extension> 
    <code value="04"/> 
    <display value="M/R"/> 
    <designation> 
      <language value="nl"/> 
      <value value="M/R"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="measles virus vaccine"/> 
    </extension> 
    <code value="05"/> 
    <display value="measles"/> 
    <designation> 
      <language value="nl"/> 
      <value value="mazelen"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="rubella virus vaccine"/> 
    </extension> 
    <code value="06"/> 
    <display value="rubella"/> 
    <designation> 
      <language value="nl"/> 
      <value value="rodehond"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="mumps virus vaccine"/> 
    </extension> 
    <code value="07"/> 
    <display value="mumps"/> 
    <designation> 
      <language value="nl"/> 
      <value value="bof"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="hepatitis B vaccine, pediatric or pediatric/adolescent dosage"/> 
    </extension> 
    <code value="08"/> 
    <display value="Hep B, adolescent or pediatric"/> 
    <designation> 
      <language value="nl"/> 
      <value value="Hep B, adolescent of pediatrie"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="tetanus and diphtheria toxoids, adsorbed for adult use"/> 
    </extension> 
    <code value="09"/> 
    <display value="Td (adult)"/> 
    <designation> 
      <language value="nl"/> 
      <value value="DT - difterie en tetanus (volwassene)"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="poliovirus vaccine, inactivated"/> 
    </extension> 
    <code value="10"/> 
    <display value="IPV"/> 
    <designation> 
      <language value="nl"/> 
      <value value="IPV"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="pneumococcal conjugate vaccine, polyvalent"/> 
    </extension> 
    <code value="100"/> 
    <display value="pneumococcal conjugate"/> 
    <designation> 
      <language value="nl"/> 
      <value value="pneumokokken conjugaat"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="typhoid Vi capsular polysaccharide vaccine"/> 
    </extension> 
    <code value="101"/> 
    <display value="typhoid, ViCPs"/> 
    <designation> 
      <language value="nl"/> 
      <value value="tyfus, ViCPs"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine"/> 
    </extension> 
    <code value="102"/> 
    <display value="DTP-Hib-Hep B"/> 
    <designation> 
      <language value="nl"/> 
      <value value="DKT-Hib-Hep B"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="meningococcal C conjugate vaccine"/> 
    </extension> 
    <code value="103"/> 
    <display value="meningococcal C conjugate"/> 
    <designation> 
      <language value="nl"/> 
      <value value="meningokokken C conjugaat"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="hepatitis A and hepatitis B vaccine"/> 
    </extension> 
    <code value="104"/> 
    <display value="Hep A-Hep B"/> 
    <designation> 
      <language value="nl"/> 
      <value value="Hep A-Hep B"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="vaccinia (smallpox) vaccine, diluted"/> 
    </extension> 
    <code value="105"/> 
    <display value="vaccinia (smallpox) diluted"/> 
    <designation> 
      <language value="nl"/> 
      <value value="vaccinia (pokken) verzwakt"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens"/> 
    </extension> 
    <code value="106"/> 
    <display value="DTaP, 5 pertussis antigens6"/> 
    <designation> 
      <language value="nl"/> 
      <value value="DaKT, 5 kinkhoest antigenen6"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="diphtheria, tetanus toxoids and acellular pertussis vaccine, NOS"/> 
    </extension> 
    <code value="107"/> 
    <display value="DTaP, NOS"/> 
    <designation> 
      <language value="nl"/> 
      <value value="DaKT, niet anders gespecificeerd"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="meningococcal vaccine, NOS"/> 
    </extension> 
    <code value="108"/> 
    <display value="meningococcal, NOS"/> 
    <designation> 
      <language value="nl"/> 
      <value value="meningokokken, niet anders gespecificeerd"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="pneumococcal vaccine, NOS"/> 
    </extension> 
    <code value="109"/> 
    <display value="pneumococcal, NOS"/> 
    <designation> 
      <language value="nl"/> 
      <value value="pneumokokken, niet anders gespecificeerd"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="pertussis vaccine"/> 
    </extension> 
    <code value="11"/> 
    <display value="pertussis"/> 
    <designation> 
      <language value="nl"/> 
      <value value="kinkhoest"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="DTaP-hepatitis B and poliovirus vaccine"/> 
    </extension> 
    <code value="110"/> 
    <display value="DTaP-Hep B-IPV"/> 
    <designation> 
      <language value="nl"/> 
      <value value="DaKT-Hep B-IPV"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="influenza virus vaccine, live, attenuated, for intranasal use"/> 
    </extension> 
    <code value="111"/> 
    <display value="influenza, live, intranasal"/> 
    <designation> 
      <language value="nl"/> 
      <value value="influenza, levend, intranasaal"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="tetanus toxoid, NOS"/> 
    </extension> 
    <code value="112"/> 
    <display value="tetanus toxoid, NOS"/> 
    <designation> 
      <language value="nl"/> 
      <value value="tetanus toxoïde, niet anders gespecificeerd"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use"/> 
    </extension> 
    <code value="113"/> 
    <display value="Td (adult)"/> 
    <designation> 
      <language value="nl"/> 
      <value value="DT - difterie en tetanus (volwassene)"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine
         (MCV4)"/> 
    </extension> 
    <code value="114"/> 
    <display value="meningococcal A,C,Y,W-135 diphtheria conjugate"/> 
    <designation> 
      <language value="nl"/> 
      <value value="meningokokken A,C,Y,W-135 difterie conjugaat"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed"/> 
    </extension> 
    <code value="115"/> 
    <display value="Tdap"/> 
    <designation> 
      <language value="nl"/> 
      <value value="tetanus toxoïde, verminderde difterie toxoïde, en acellulaire kinkhoest"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="rotavirus, live, pentavalent vaccine"/> 
    </extension> 
    <code value="116"/> 
    <display value="rotavirus, pentavalent"/> 
    <designation> 
      <language value="nl"/> 
      <value value="rotavirus, pentavalent"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="varicella zoster immune globulin (Investigational New Drug)"/> 
    </extension> 
    <code value="117"/> 
    <display value="VZIG (IND)"/> 
    <designation> 
      <language value="nl"/> 
      <value value="VZIG (IND)"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="human papilloma virus vaccine, bivalent"/> 
    </extension> 
    <code value="118"/> 
    <display value="HPV, bivalent"/> 
    <designation> 
      <language value="nl"/> 
      <value value="HPV, bivalent"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="rotavirus, live, monovalent vaccine"/> 
    </extension> 
    <code value="119"/> 
    <display value="rotavirus, monovalent"/> 
    <designation> 
      <language value="nl"/> 
      <value value="rotavirus, monovalent"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="diphtheria antitoxin"/> 
    </extension> 
    <code value="12"/> 
    <display value="diphtheria antitoxin"/> 
    <designation> 
      <language value="nl"/> 
      <value value="difterie antitoxine"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type
         b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)"/> 
    </extension> 
    <code value="120"/> 
    <display value="DTaP-Hib-IPV"/> 
    <designation> 
      <language value="nl"/> 
      <value value="DaKT-Hib-IPV"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="zoster vaccine, live"/> 
    </extension> 
    <code value="121"/> 
    <display value="zoster"/> 
    <designation> 
      <language value="nl"/> 
      <value value="gordelroos"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="rotavirus vaccine, NOS"/> 
    </extension> 
    <code value="122"/> 
    <display value="rotavirus, NOS1"/> 
    <designation> 
      <language value="nl"/> 
      <value value="rotavirus, niet anders gespecificeerd1"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="tetanus immune globulin"/> 
    </extension> 
    <code value="13"/> 
    <display value="TIG"/> 
    <designation> 
      <language value="nl"/> 
      <value value="TIG"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="immune globulin, NOS"/> 
    </extension> 
    <code value="14"/> 
    <display value="IG, NOS"/> 
    <designation> 
      <language value="nl"/> 
      <value value="IG, niet anders gespecificeerd"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="influenza virus vaccine, split virus (incl. purified surface antigen)"/> 
    </extension> 
    <code value="15"/> 
    <display value="influenza, split (incl. purified surface antigen)"/> 
    <designation> 
      <language value="nl"/> 
      <value value="influenza, gesplitst (incl. gezuiverd oppervlakte antigen)"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="influenza virus vaccine, whole virus"/> 
    </extension> 
    <code value="16"/> 
    <display value="influenza, whole"/> 
    <designation> 
      <language value="nl"/> 
      <value value="influenza, geheel"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="Haemophilus influenzae type b vaccine, conjugate NOS"/> 
    </extension> 
    <code value="17"/> 
    <display value="Hib, NOS"/> 
    <designation> 
      <language value="nl"/> 
      <value value="Hib, niet anders gespecificeerd"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="rabies vaccine, for intramuscular injection"/> 
    </extension> 
    <code value="18"/> 
    <display value="rabies, intramuscular injection"/> 
    <designation> 
      <language value="nl"/> 
      <value value="hondsdolheid, intramusculaire injectie"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="Bacillus Calmette-Guerin vaccine"/> 
    </extension> 
    <code value="19"/> 
    <display value="BCG"/> 
    <designation> 
      <language value="nl"/> 
      <value value="BCG"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="diphtheria, tetanus toxoids and acellular pertussis vaccine"/> 
    </extension> 
    <code value="20"/> 
    <display value="DTaP"/> 
    <designation> 
      <language value="nl"/> 
      <value value="DaKT -difterie-acellulaire kinkhoest-tetanus"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="varicella virus vaccine"/> 
    </extension> 
    <code value="21"/> 
    <display value="varicella"/> 
    <designation> 
      <language value="nl"/> 
      <value value="varicella"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="DTP-Haemophilus influenzae type b conjugate vaccine"/> 
    </extension> 
    <code value="22"/> 
    <display value="DTP-Hib"/> 
    <designation> 
      <language value="nl"/> 
      <value value="DKT-Hib"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="plague vaccine"/> 
    </extension> 
    <code value="23"/> 
    <display value="plague"/> 
    <designation> 
      <language value="nl"/> 
      <value value="pest"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="anthrax vaccine"/> 
    </extension> 
    <code value="24"/> 
    <display value="anthrax"/> 
    <designation> 
      <language value="nl"/> 
      <value value="miltvuur"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="typhoid vaccine, live, oral"/> 
    </extension> 
    <code value="25"/> 
    <display value="typhoid, oral"/> 
    <designation> 
      <language value="nl"/> 
      <value value="tyfus, oral"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="cholera vaccine"/> 
    </extension> 
    <code value="26"/> 
    <display value="cholera"/> 
    <designation> 
      <language value="nl"/> 
      <value value="cholera"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="botulinum antitoxin"/> 
    </extension> 
    <code value="27"/> 
    <display value="botulinum antitoxin"/> 
    <designation> 
      <language value="nl"/> 
      <value value="botulisme antitoxine"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="diphtheria and tetanus toxoids, adsorbed for pediatric use"/> 
    </extension> 
    <code value="28"/> 
    <display value="DT (pediatric)"/> 
    <designation> 
      <language value="nl"/> 
      <value value="DT - difterie-tetanus (pediatrie)"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="cytomegalovirus immune globulin, intravenous"/> 
    </extension> 
    <code value="29"/> 
    <display value="CMVIG"/> 
    <designation> 
      <language value="nl"/> 
      <value value="CMVIG"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="hepatitis B immune globulin"/> 
    </extension> 
    <code value="30"/> 
    <display value="HBIG"/> 
    <designation> 
      <language value="nl"/> 
      <value value="HBIG"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="hepatitis A vaccine, pediatric dosage, NOS"/> 
    </extension> 
    <code value="31"/> 
    <display value="Hep A, pediatric, NOS"/> 
    <designation> 
      <language value="nl"/> 
      <value value="Hep A, pediatrie, niet anders gespecificeerd"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="meningococcal polysaccharide vaccine (MPSV4)"/> 
    </extension> 
    <code value="32"/> 
    <display value="meningococcal"/> 
    <designation> 
      <language value="nl"/> 
      <value value="meningokokken"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="pneumococcal polysaccharide vaccine"/> 
    </extension> 
    <code value="33"/> 
    <display value="pneumococcal"/> 
    <designation> 
      <language value="nl"/> 
      <value value="pneumokokken"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="rabies immune globulin"/> 
    </extension> 
    <code value="34"/> 
    <display value="RIG"/> 
    <designation> 
      <language value="nl"/> 
      <value value="hondsdolheid immunoglobuline"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="tetanus toxoid, adsorbed"/> 
    </extension> 
    <code value="35"/> 
    <display value="tetanus toxoid"/> 
    <designation> 
      <language value="nl"/> 
      <value value="tetanus toxoïde"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="varicella zoster immune globulin"/> 
    </extension> 
    <code value="36"/> 
    <display value="VZIG"/> 
    <designation> 
      <language value="nl"/> 
      <value value="VZIG"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="yellow fever vaccine"/> 
    </extension> 
    <code value="37"/> 
    <display value="yellow fever"/> 
    <designation> 
      <language value="nl"/> 
      <value value="gele koorts"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="rubella and mumps virus vaccine"/> 
    </extension> 
    <code value="38"/> 
    <display value="rubella/mumps"/> 
    <designation> 
      <language value="nl"/> 
      <value value="rodehond/bof"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="Japanese encephalitis vaccine"/> 
    </extension> 
    <code value="39"/> 
    <display value="Japanese encephalitis"/> 
    <designation> 
      <language value="nl"/> 
      <value value="Japanse encefalitis"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="rabies vaccine, for intradermal injection"/> 
    </extension> 
    <code value="40"/> 
    <display value="rabies, intradermal injection"/> 
    <designation> 
      <language value="nl"/> 
      <value value="hondsdolheid, intradermale injectie"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="typhoid vaccine, parenteral, other than acetone-killed, dried"/> 
    </extension> 
    <code value="41"/> 
    <display value="typhoid, parenteral"/> 
    <designation> 
      <language value="nl"/> 
      <value value="tyfus, parenteraal"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="hepatitis B vaccine, adolescent/high risk infant dosage"/> 
    </extension> 
    <code value="42"/> 
    <display value="Hep B, adolescent/high risk infant2"/> 
    <designation> 
      <language value="nl"/> 
      <value value="Hep B, adolescent/hoogrisico zuigeling2"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="hepatitis B vaccine, adult dosage"/> 
    </extension> 
    <code value="43"/> 
    <display value="Hep B, adult4"/> 
    <designation> 
      <language value="nl"/> 
      <value value="Hep B, volwassen4"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="hepatitis B vaccine, dialysis patient dosage"/> 
    </extension> 
    <code value="44"/> 
    <display value="Hep B, dialysis"/> 
    <designation> 
      <language value="nl"/> 
      <value value="Hep B, dialyse"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="hepatitis B vaccine, NOS"/> 
    </extension> 
    <code value="45"/> 
    <display value="Hep B, NOS"/> 
    <designation> 
      <language value="nl"/> 
      <value value="Hep B, niet anders gespecificeerd"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="Haemophilus influenzae type b vaccine, PRP-D conjugate"/> 
    </extension> 
    <code value="46"/> 
    <display value="Hib (PRP-D)"/> 
    <designation> 
      <language value="nl"/> 
      <value value="Hib (PRP-D)"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="Haemophilus influenzae type b vaccine, HbOC conjugate"/> 
    </extension> 
    <code value="47"/> 
    <display value="Hib (HbOC)"/> 
    <designation> 
      <language value="nl"/> 
      <value value="Hib (HbOC)"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="Haemophilus influenzae type b vaccine, PRP-T conjugate"/> 
    </extension> 
    <code value="48"/> 
    <display value="Hib (PRP-T)"/> 
    <designation> 
      <language value="nl"/> 
      <value value="Hib (PRP-T)"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="Haemophilus influenzae type b vaccine, PRP-OMP conjugate"/> 
    </extension> 
    <code value="49"/> 
    <display value="Hib (PRP-OMP)"/> 
    <designation> 
      <language value="nl"/> 
      <value value="Hib (PRP-OMP)"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="DTaP-Haemophilus influenzae type b conjugate vaccine"/> 
    </extension> 
    <code value="50"/> 
    <display value="DTaP-Hib"/> 
    <designation> 
      <language value="nl"/> 
      <value value="DaKT-Hib"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="Haemophilus influenzae type b conjugate and Hepatitis B vaccine"/> 
    </extension> 
    <code value="51"/> 
    <display value="Hib-Hep B"/> 
    <designation> 
      <language value="nl"/> 
      <value value="Hib-Hep B"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="hepatitis A vaccine, adult dosage"/> 
    </extension> 
    <code value="52"/> 
    <display value="Hep A, adult"/> 
    <designation> 
      <language value="nl"/> 
      <value value="Hep A, volwassene"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)"/> 
    </extension> 
    <code value="53"/> 
    <display value="typhoid, parenteral, AKD (U.S. military)"/> 
    <designation> 
      <language value="nl"/> 
      <value value="tyfus, parenteraal, AKD (Amerikaanse leger)"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="adenovirus vaccine, type 4, live, oral"/> 
    </extension> 
    <code value="54"/> 
    <display value="adenovirus, type 4"/> 
    <designation> 
      <language value="nl"/> 
      <value value="adenovirus, type 4"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="adenovirus vaccine, type 7, live, oral"/> 
    </extension> 
    <code value="55"/> 
    <display value="adenovirus, type 7"/> 
    <designation> 
      <language value="nl"/> 
      <value value="adenovirus, type 7"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="dengue fever vaccine"/> 
    </extension> 
    <code value="56"/> 
    <display value="dengue fever"/> 
    <designation> 
      <language value="nl"/> 
      <value value="knokkelkoorts"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="hantavirus vaccine"/> 
    </extension> 
    <code value="57"/> 
    <display value="hantavirus"/> 
    <designation> 
      <language value="nl"/> 
      <value value="hantavirus"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="hepatitis C vaccine"/> 
    </extension> 
    <code value="58"/> 
    <display value="Hep C"/> 
    <designation> 
      <language value="nl"/> 
      <value value="Hep C"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="hepatitis E vaccine"/> 
    </extension> 
    <code value="59"/> 
    <display value="Hep E"/> 
    <designation> 
      <language value="nl"/> 
      <value value="Hep E"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="herpes simplex virus, type 2 vaccine"/> 
    </extension> 
    <code value="60"/> 
    <display value="herpes simplex 2"/> 
    <designation> 
      <language value="nl"/> 
      <value value="herpes simplex 2"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="human immunodeficiency virus vaccine"/> 
    </extension> 
    <code value="61"/> 
    <display value="HIV"/> 
    <designation> 
      <language value="nl"/> 
      <value value="HIV"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="human papilloma virus vaccine, quadrivalent"/> 
    </extension> 
    <code value="62"/> 
    <display value="HPV, quadrivalent"/> 
    <designation> 
      <language value="nl"/> 
      <value value="HPV, quadrivalent"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="Junin virus vaccine"/> 
    </extension> 
    <code value="63"/> 
    <display value="Junin virus"/> 
    <designation> 
      <language value="nl"/> 
      <value value="Junín virus"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="leishmaniasis vaccine"/> 
    </extension> 
    <code value="64"/> 
    <display value="leishmaniasis"/> 
    <designation> 
      <language value="nl"/> 
      <value value="leishmaniase"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="leprosy vaccine"/> 
    </extension> 
    <code value="65"/> 
    <display value="leprosy"/> 
    <designation> 
      <language value="nl"/> 
      <value value="lepra"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="Lyme disease vaccine"/> 
    </extension> 
    <code value="66"/> 
    <display value="Lyme disease"/> 
    <designation> 
      <language value="nl"/> 
      <value value="ziekte van Lyme"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="malaria vaccine"/> 
    </extension> 
    <code value="67"/> 
    <display value="malaria"/> 
    <designation> 
      <language value="nl"/> 
      <value value="malaria"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="melanoma vaccine"/> 
    </extension> 
    <code value="68"/> 
    <display value="melanoma"/> 
    <designation> 
      <language value="nl"/> 
      <value value="melanoom"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="parainfluenza-3 virus vaccine"/> 
    </extension> 
    <code value="69"/> 
    <display value="parainfluenza-3"/> 
    <designation> 
      <language value="nl"/> 
      <value value="parainfluenza-3"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="Q fever vaccine"/> 
    </extension> 
    <code value="70"/> 
    <display value="Q fever"/> 
    <designation> 
      <language value="nl"/> 
      <value value="Q-koorts"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="respiratory syncytial virus immune globulin, intravenous"/> 
    </extension> 
    <code value="71"/> 
    <display value="RSV-IGIV"/> 
    <designation> 
      <language value="nl"/> 
      <value value="RSV-IGIV"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="rheumatic fever vaccine"/> 
    </extension> 
    <code value="72"/> 
    <display value="rheumatic fever"/> 
    <designation> 
      <language value="nl"/> 
      <value value="reumatische koorts"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="Rift Valley fever vaccine"/> 
    </extension> 
    <code value="73"/> 
    <display value="Rift Valley fever"/> 
    <designation> 
      <language value="nl"/> 
      <value value="Riftdalkoorts"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="rotavirus, live, tetravalent vaccine"/> 
    </extension> 
    <code value="74"/> 
    <display value="rotavirus, tetravalent"/> 
    <designation> 
      <language value="nl"/> 
      <value value="rotavirus, tetravalent"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="vaccinia (smallpox) vaccine"/> 
    </extension> 
    <code value="75"/> 
    <display value="vaccinia (smallpox)"/> 
    <designation> 
      <language value="nl"/> 
      <value value="vaccinia (pokken)"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="Staphylococcus bacteriophage lysate"/> 
    </extension> 
    <code value="76"/> 
    <display value="Staphylococcus bacterio lysate"/> 
    <designation> 
      <language value="nl"/> 
      <value value="Staphylococcus bacterio lysate"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="tick-borne encephalitis vaccine"/> 
    </extension> 
    <code value="77"/> 
    <display value="tick-borne encephalitis"/> 
    <designation> 
      <language value="nl"/> 
      <value value="frühsommer-meningoenzephalitis vaccin"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="tularemia vaccine"/> 
    </extension> 
    <code value="78"/> 
    <display value="tularemia vaccine"/> 
    <designation> 
      <language value="nl"/> 
      <value value="tularemia vaccin"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="vaccinia immune globulin"/> 
    </extension> 
    <code value="79"/> 
    <display value="vaccinia immune globulin"/> 
    <designation> 
      <language value="nl"/> 
      <value value="vaccinia immunoglobuline"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="Venezuelan equine encephalitis, live, attenuated"/> 
    </extension> 
    <code value="80"/> 
    <display value="VEE, live"/> 
    <designation> 
      <language value="nl"/> 
      <value value="VEE, levend"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="Venezuelan equine encephalitis, inactivated"/> 
    </extension> 
    <code value="81"/> 
    <display value="VEE, inactivated"/> 
    <designation> 
      <language value="nl"/> 
      <value value="VEE, inactief"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="adenovirus vaccine, NOS"/> 
    </extension> 
    <code value="82"/> 
    <display value="adenovirus, NOS1"/> 
    <designation> 
      <language value="nl"/> 
      <value value="adenovirus, niet anders gespecificeerd1"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule"/> 
    </extension> 
    <code value="83"/> 
    <display value="Hep A, ped/adol, 2 dose"/> 
    <designation> 
      <language value="nl"/> 
      <value value="Hep A, ped/adol, 2 dosis"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule"/> 
    </extension> 
    <code value="84"/> 
    <display value="Hep A, ped/adol, 3 dose"/> 
    <designation> 
      <language value="nl"/> 
      <value value="Hep A, ped/adol, 3 dosis"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="hepatitis A vaccine, NOS"/> 
    </extension> 
    <code value="85"/> 
    <display value="Hep A, NOS"/> 
    <designation> 
      <language value="nl"/> 
      <value value="Hep A, niet anders gespecificeerd"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="immune globulin, intramuscular"/> 
    </extension> 
    <code value="86"/> 
    <display value="IG"/> 
    <designation> 
      <language value="nl"/> 
      <value value="IG"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="immune globulin, intravenous"/> 
    </extension> 
    <code value="87"/> 
    <display value="IGIV"/> 
    <designation> 
      <language value="nl"/> 
      <value value="IGIV"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="influenza virus vaccine, NOS"/> 
    </extension> 
    <code value="88"/> 
    <display value="influenza, NOS"/> 
    <designation> 
      <language value="nl"/> 
      <value value="influenza, niet anders gespecificeerd"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="poliovirus vaccine, NOS"/> 
    </extension> 
    <code value="89"/> 
    <display value="polio, NOS"/> 
    <designation> 
      <language value="nl"/> 
      <value value="polio, niet anders gespecificeerd"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="rabies vaccine, NOS"/> 
    </extension> 
    <code value="90"/> 
    <display value="rabies, NOS"/> 
    <designation> 
      <language value="nl"/> 
      <value value="hondsdolheid, niet anders gespecificeerd"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="typhoid vaccine, NOS"/> 
    </extension> 
    <code value="91"/> 
    <display value="typhoid, NOS"/> 
    <designation> 
      <language value="nl"/> 
      <value value="tyfus, niet anders gespecificeerd"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="Venezuelan equine encephalitis vaccine, NOS"/> 
    </extension> 
    <code value="92"/> 
    <display value="VEE, NOS"/> 
    <designation> 
      <language value="nl"/> 
      <value value="VEE, niet anders gespecificeerd"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular"/> 
    </extension> 
    <code value="93"/> 
    <display value="RSV-MAb"/> 
    <designation> 
      <language value="nl"/> 
      <value value="RSV-MAb"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="measles, mumps, rubella, and varicella virus vaccine"/> 
    </extension> 
    <code value="94"/> 
    <display value="MMRV"/> 
    <designation> 
      <language value="nl"/> 
      <value value="BMRV - bof, mazelen, rodehond en varicella"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="tuberculin skin test; old tuberculin, multipuncture device"/> 
    </extension> 
    <code value="95"/> 
    <display value="TST-OT tine test"/> 
    <designation> 
      <language value="nl"/> 
      <value value="TST-OT tine test"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="tuberculin skin test; purified protein derivative solution, intradermal"/> 
    </extension> 
    <code value="96"/> 
    <display value="TST-PPD intradermal"/> 
    <designation> 
      <language value="nl"/> 
      <value value="TST-PPD intradermal"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="tuberculin skin test; purified protein derivative, multipuncture device"/> 
    </extension> 
    <code value="97"/> 
    <display value="TST-PPD tine test"/> 
    <designation> 
      <language value="nl"/> 
      <value value="TST-PPD tine test"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="tuberculin skin test; NOS"/> 
    </extension> 
    <code value="98"/> 
    <display value="TST, NOS"/> 
    <designation> 
      <language value="nl"/> 
      <value value="TST, niet anders gespecificeerd"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="RESERVED - do not use"/> 
    </extension> 
    <code value="99"/> 
    <display value="RESERVED - do not use3"/> 
    <designation> 
      <language value="nl"/> 
      <value value="GERESERVEERD - niet gebruiken3"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="no vaccine administered"/> 
    </extension> 
    <code value="998"/> 
    <display value="no vaccine administered5"/> 
    <designation> 
      <language value="nl"/> 
      <value value="geen vaccin toegediend5"/> 
    </designation> 
  </concept> 
  <concept> 
    <extension url="http://hl7.org/fhir/StructureDefinition/codesystem-comments">
      <valueString value="unknown vaccine or immune globulin"/> 
    </extension> 
    <code value="999"/> 
    <display value="unknown"/> 
    <designation> 
      <language value="nl"/> 
      <value value="onbekend"/> 
    </designation> 
  </concept> 
</CodeSystem>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.